BIOMAT Database Logo BIOMAT Database Logo

Effect of methyl-p-tyrosine administration on gonadotropin and prolactin release in normal-cycling, postmenopausal and hyperprolactinemic women. 1981

I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008781 Methyltyrosines A group of compounds that are methyl derivatives of the amino acid TYROSINE.
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D005260 Female Females
D005498 Follicular Phase The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION. Menstrual Cycle, Follicular Phase,Menstrual Cycle, Proliferative Phase,Menstrual Proliferative Phase,Preovulatory Phase,Phase, Follicular,Phase, Menstrual Proliferative,Phase, Preovulatory,Proliferative Phase, Menstrual
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
April 1979, The Journal of clinical endocrinology and metabolism,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Effect of fenfluramine oral administration on serum prolactin levels in healthy and hyperprolactinemic women.
January 1985, Gynecologic and obstetric investigation,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Serotoninergic involvement in gonadotropin and TSH secretion in normal cycling and postmenopausal women.
January 1998, Hormone research,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
June 1984, The Journal of clinical endocrinology and metabolism,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Effect of human corticotropin-releasing hormone on gonadotropin secretion in cycling and postmenopausal women.
December 1992, Fertility and sterility,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
September 1987, The Journal of clinical endocrinology and metabolism,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Effect of human prolactin administration on gonadotropin and thyrotropin secretion in normal men.
September 1993, Journal of endocrinological investigation,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
April 1989, Obstetrics and gynecology,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
January 1989, Hormone research,
I Nicoletti, and P Filipponi, and L Fedeli, and G Angeletti, and F Santeusanio, and P Brunetti
Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
August 2002, Clinical endocrinology,
Copied contents to your clipboard!